Long‐term outcome of high‐grade encapsulated papillary carcinoma of the breast: implications for staging and management
Histopathology · 2026-12 · 89 (6) · 941-953
DOI: 10.1111/his.70240 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Histopathology, online erschienen am 03.08.2026. Verfasst von Milena Stevanovic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Encapsulated papillary carcinoma (EPC) of the breast is an uncommon tumour with controversial biological behaviour and staging. Emerging evidence suggests that EPC with adverse pathological features (EPC‐A) may exhibit invasive potential. The absence of uniform staging criteria contributes to management variability. This study evaluates the clinicopathological characteristics and clinical course of high‐grade EPC (HG‐EPC), including EPC‐A. Materials and methods This retrospective multicentre study (2000–2025) included 25 HG‐EPC cases, irrespectively of ER/PR and HER2 status. Tumours with frank stromal invasion beyond microinvasive foci were excluded. Histopathological re‐evaluation was performed in accordance with 2019 WHO classification criteria.
Results
Of 38 cases reviewed, 25 fulfilled the inclusion criteria as EPC (mean age 57.2 years, mean tumour size 2.9 cm). Six cases (24%) demonstrated conventional‐type microinvasive components. A subset of 16 cases fulfilled criteria for EPC‐A, defined by high‐grade morphology in combination with ER/PR‐negative (or ER
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- School of Medicine, University Nottingham, Nottingham, UK.
- Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Breast Center Seefeld, Zurich, Switzerland.
- Breast Center, Hospital Zollikerberg, Zollikerberg, Switzerland.
- Breast Center, Department of Gynecology, University Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Milena Stevanovic, Emad Rakha, Hisham Fansa, Isabell Witzel, Zsuzsanna Varga
Zitieren
APA
Stevanovic, M., Rakha, E., Ellis, I. O., Maccio, U., Papassotiropoulos, B., Fansa, H., Stevanovic, L., Frauchiger-Heuer, H., Witzel, I., & Varga, Z. (2026). Long‐term outcome of high‐grade encapsulated papillary carcinoma of the breast: implications for staging and management. Histopathology, 89(6), 941-953. https://doi.org/10.1111/his.70240
Vancouver
Stevanovic M, Rakha E, Ellis IO, Maccio U, Papassotiropoulos B, Fansa H, et al. Long‐term outcome of high‐grade encapsulated papillary carcinoma of the breast: implications for staging and management. Histopathology. 2026;89(6):941-953. doi:10.1111/his.70240
BibTeX
@article{Stevanovic2026,
author = {Stevanovic, Milena and Rakha, Emad and Ellis, Ian O and Maccio, Umberto and Papassotiropoulos, Bärbel and Fansa, Hisham and Stevanovic, Lidija and Frauchiger-Heuer, Heike and Witzel, Isabell and Varga, Zsuzsanna},
title = {Long‐term outcome of high‐grade encapsulated papillary carcinoma of the breast: implications for staging and management},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {6},
pages = {941--953},
doi = {10.1111/his.70240}
}
EUVIMED